Related Experiment Video

Updated: Jul 6, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Depression in the elderly

George S Alexopoulos1

  • 1Weill Medical College of Cornell University and Weill-Cornell Institute of Geriatric Psychiatry, 21 Bloomingdale Road, White Plains, New York, NY 10605, USA. gsalexop@med.cornell.edu

Lancet (London, England)
|June 7, 2005
PubMed

Insights

Late-life depression significantly impacts older adults, especially those with chronic illnesses. Effective treatments exist, but inadequate insurance coverage in North America hinders access to care for elderly depression.

Area of Science:

  • Gerontology
  • Psychiatry
  • Neuroscience

Background:

  • Late-life depression is prevalent in elderly individuals with chronic medical conditions and cognitive impairment.
  • It leads to significant suffering, disability, family disruption, and increased mortality.
  • Ageing and disease processes affect brain regions crucial for mood regulation, increasing vulnerability.

Purpose of the Study:

  • To review the impact of depression in the elderly.
  • To discuss the biological and psychosocial factors contributing to late-life depression.
  • To evaluate current treatment and prevention strategies for elderly depression.

Main Methods:

  • Literature review of studies on late-life depression.
  • Analysis of biological mechanisms (arteriosclerosis, inflammation, endocrine/immune changes) affecting brain pathways.
  • Examination of psychosocial adversity factors (poverty, isolation, bereavement).

Main Results:

  • Antidepressant treatment is well-tolerated and effective in older adults, comparable to younger populations.
  • Evidence-based guidelines and care systems for prevention and treatment are available.
  • Inadequate public insurance coverage in North America limits access to these services.

Conclusions:

  • Depression in the elderly is a serious condition influenced by biological and psychosocial factors.
  • Effective interventions exist, but healthcare access remains a challenge due to insufficient insurance coverage.
  • Improving access to care is crucial for managing and preventing depression in older adults.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Therapeutic Massage for Psychological Well-being in Geriatric Oncology03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...